Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UK Denies Pfizer’s Bid To Clear Path For Biosimilar Bevacizumab
Jun 21 2019
•
By
Aidan Fry
Pfizer has failed to get an Arrow declaration from a UK court against patents sought by Roche for its Avastin bevacizumab brand • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin